Back
BeiGene Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
35
BGNE
BeiGene
Last Price:
207.51
Seasonality Move:
13.54%
Sell
48
BMRN
Biomarin Pharmaceutical
Last Price:
66.00
Seasonality Move:
14.81%
Sell
35
BeiGene (BGNE)
is a Sell
Is BeiGene a Buy, Sell or Hold?
- The current BeiGene [BGNE] share price is $204.21. The Score for BGNE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- BGNE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $66.60. The Score for BMRN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
BGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.07 | Sell |
| Relative Strength Index (14 RSI): | 39.19 | Sell |
| Chaikin Money Flow: | -140998 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (212.53 - 236.09) | Sell |
| Bollinger Bands (100): | (158.06 - 216.04) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.86 | Sell |
| Relative Strength Index (14 RSI): | 31.12 | Sell |
| Chaikin Money Flow: | 1072649 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (68.2 - 70.76) | Sell |
| Bollinger Bands (100): | (72.25 - 88.57) | Sell |
BGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 211.82 | Sell |
| 20-day SMA: | 223.29 | Sell |
| 50-day SMA: | 211.3 | Sell |
| 200-day SMA: | 171.46 | Buy |
| 8-day EMA: | 210.89 | Sell |
| 20-day EMA: | 216.1 | Sell |
| 50-day EMA: | 209.26 | Sell |
| 200-day EMA: | 185.44 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.66 | Sell |
| 20-day SMA: | 69.42 | Sell |
| 50-day SMA: | 75.52 | Sell |
| 200-day SMA: | 82.98 | Sell |
| 8-day EMA: | 68.12 | Sell |
| 20-day EMA: | 69.64 | Sell |
| 50-day EMA: | 73.86 | Sell |
| 200-day EMA: | 81.73 | Sell |
BeiGene Earnings Growth & BGNE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.08 per share, and an increase next year of $4.67 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.24 per share, and an increase next year of $0.79 per share.
BeiGene Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||